Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?

Early Breast Cancer Trialists' Collaborative Group, None, Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. The Lancet. ,vol. 379, pp. 432- 444 ,(2012) , 10.1016/S0140-6736(11)61625-5

Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0

H M Earl, , L Hiller, J A Dunn, S Bathers, P Harvey, A Stanley, R J Grieve, R K Agrawal, I N Fernando, A M Brunt, K McAdam, S O'Reilly, D W Rea, D Spooner, C J Poole, NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life. British Journal of Cancer. ,vol. 99, pp. 1226- 1231 ,(2008) , 10.1038/SJ.BJC.6604674

Richard Simon, Larry Norton, The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens Nature Reviews Clinical Oncology. ,vol. 3, pp. 406- 407 ,(2006) , 10.1038/NCPONC0560

Marco Venturini, Lucia Del Mastro, Enrico Aitini, Editta Baldini, Cinzia Caroti, Antonio Contu, Franco Testore, Fulvio Brema, Paolo Pronzato, Giovanna Cavazzini, Mario Roberto Sertoli, Giuseppe Canavese, Riccardo Rosso, Paolo Bruzzi, Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial Journal of the National Cancer Institute. ,vol. 97, pp. 1724- 1733 ,(2005) , 10.1093/JNCI/DJI398

L Del Mastro, , P Bruzzi, G Nicolò, G Cavazzini, A Contu, M D'Amico, A Lavarello, F Testore, B Castagneto, E Aitini, L Perdelli, C Bighin, R Rosso, Marco Venturini, HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients. British Journal of Cancer. ,vol. 93, pp. 7- 14 ,(2005) , 10.1038/SJ.BJC.6602660

Marc L. Citron, Donald A. Berry, Constance Cirrincione, Clifford Hudis, Eric P. Winer, William J. Gradishar, Nancy E. Davidson, Silvana Martino, Robert Livingston, James N. Ingle, Edith A. Perez, John Carpenter, David Hurd, James F. Holland, Barbara L. Smith, Carolyn I. Sartor, Eleanor H. Leung, Jeffrey Abrams, Richard L. Schilsky, Hyman B. Muss, Larry Norton, Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 Journal of Clinical Oncology. ,vol. 21, pp. 1431- 1439 ,(2003) , 10.1200/JCO.2003.09.081

Nan Shao, Shenming Wang, Chen Yao, Xiangdong Xu, Yunjian Zhang, Yuanyuan Zhang, Ying Lin, Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: A meta-analysis of phase III randomized control trials The Breast. ,vol. 21, pp. 389- 393 ,(2012) , 10.1016/J.BREAST.2012.03.011

EP Mamounas, G Tang, S Paik, FL Baehner, Q Liu, J-H Jeong, S-R Kim, SM Butler, F Jamshidian, DB Cherbavaz, AP Sing, S Shak, TB Julian, BC Lembersky, DL Wickerham, JP Costantino, N Wolmark, Abstract S1-10: Association between the 21-gene recurrence score (RS) and benefit from adjuvant paclitaxel (Pac) in node-positive (N+), ER-positive breast cancer patients (pts): Results from NSABP B-28 Cancer Research. ,vol. 72, ,(2012) , 10.1158/0008-5472.SABCS12-S1-10

Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant, Joseph P Costantino, Charles E Geyer Jr, D Lawrence Wickerham, Norman Wolmark, None, Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer Journal of Clinical Oncology. ,vol. 24, pp. 3726- 3734 ,(2006) , 10.1200/JCO.2005.04.7985